Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
ICICI Pru Nifty Pharma Index Fund-Reg(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Ltd.21.380812313619.6439
Domestic EquitiesDivi's Laboratories Ltd.9.7309147758.9404
Domestic EquitiesCipla Ltd.9.4288654298.6628
Domestic EquitiesDr. Reddy's Laboratories Ltd.9.3951708648.6319
Domestic EquitiesLupin Ltd.6.6051281896.0685
Domestic EquitiesTorrent Pharmaceuticals Ltd.5.2439121644.8179
Domestic EquitiesLaurus Labs Ltd.4.7456451824.3601
Domestic EquitiesAurobindo Pharma Ltd.4.2755325263.9282
Domestic EquitiesAlkem Laboratories Ltd.4.205168053.8635
Domestic EquitiesGlenmark Pharmaceuticals Ltd.3.8421175113.5300
Domestic EquitiesBiocon Ltd.3.3127829763.0436
Domestic EquitiesMankind Pharma Ltd.3.0401131502.7931
Domestic EquitiesZydus Lifesciences Ltd.2.8038290982.5760
Domestic EquitiesIPCA Laboratories Ltd.2.5872161612.3770
Domestic EquitiesJ.B.Chemicals & Pharmaceuticals Ltd.1.934495071.7773
Domestic EquitiesGland Pharma Ltd.1.859692521.7085
Domestic EquitiesAbbott India Ltd.1.81816061.6704
Domestic EquitiesAjanta Pharma Ltd.1.482848971.3623
Domestic EquitiesWockhardt Ltd.1.444996041.3275
Domestic EquitiesPiramal Pharma Ltd.1.2114719541.1130
Total 100.3479 92.1959
Cash & Cash Equivalents and Net AssetsTREPS1.1462 1.0531
Cash & Cash Equivalents and Net AssetsNet Current Assets-1.4941 -1.3728
Total -0.3479 -0.3197
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.